Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metvix + Daylight for Facial Photodamage
NCT02139618Phase 2Completed
- Sponsor
- Dermabase
- Start
- Apr 2014
- Primary completion
- Oct 2014
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of methyl aminolevulinate in facial photodamage, sponsored by Dermabase. Started Apr 2014; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
facial photodamage
Beyond the preview
Go deeper on NCT02139618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139618.